Main Conference

In-house counsel forum

Chemical and pharmaceutical industry | In-house counsel | International transport and inspection | Risk management

Programme


8:30 AM | Welcome coffee


9:00 AM | Welcome address


9:15 AM | International transport and inspection

Moderator

Speakers

  • Oliver Drennan
    Group General Counsel, SITA
  • Florence Schurch
    Secretary General, SUISSENÉGOCE
  • Julien Raynaut
    VP Legal & Compliance General Counsel and Compliance Officer, Bureau Veritas

10:00 AM | Bridging science and law: contracts, IP, and compliance in pharma & chemicals

This panel will explore the key legal challenges shaping the pharmaceutical and chemical sectors in Switzerland. Experts will discuss trends in contracts, intellectual property, and regulatory compliance, focusing on how law can drive innovation and collaboration. Topics include protecting inventions, structuring strategic partnerships, and navigating global regulatory requirements, with practical insights on managing risk and optimizing R&D agreements in a complex legal landscape.


Moderator

Speakers

  • Gilles Aebischer
    Head of Market Access and Public Affairs Swiss Affiliate, OM Pharma Suisse SA
  • Luisa Amate
    Lead Counsel, Corteva Agriscience
  • Gavin Pope
    Head of R&D Legal, Global Clinical Development, Operations & Regulatory, Novartis
  • Laetitia Pictet
    Chief Legal, Risk and Compliance Officer, DSM-Firmenich

10:45 AM | Coffee break


11:15 AM | Risk management from the boardroom to the courtroom: the art of in‑house legal strategy

In‑house counsel play a discreet yet pivotal role in managing corporate risk. This panel explores the tension between legal and business imperatives, the link between governance and legal strategy, and the evolving place of the legal function within corporate structures. Topics include dispute and crisis management, reputational risk, and professional secrecy – all central to the modern counsel’s mandate.


Moderator

  • Jean-Philippe Nerfin
    Group General Counsel, Pictet

Speakers

  • Isabelle Berger
    Chief Investment Officer & Partner, Nivalion
  • Xavier Dedullen
    Managing Director, Kroll
  • Nicolas Grégoire
    Head of Compliance, Richemont International SA

12:00 PM | Closing remarks

  • Laure Lavorel
    Senior Associate General Counsel, Broadcom
  • Jean-René Oettli
    Partner, Borel & Barbey

12:15 PM | Networking lunch

Schedule

Tuesday 10 March
08:30 – 12:15

Location

Mandarin Oriental
Quai Turrettini 1, 1201 Genève
www.mandarinoriental.com
Map

Speakers

  • Aurélie Conrad Hari

    Partner, Bär & Karrer (Geneva) | Vice-President GILA
  • Florence Schurch

    Secretary General, SUISSENÉGOCE
  • Gavin Pope

    Head of R&D Legal, Global Clinical Development, Operations & Regulatory, Novartis
  • Gilles Aebischer

    Head of Market Access and Public Affairs Swiss Affiliate, OM Pharma Suisse SA
  • Isabelle Berger

    Chief Investment Officer & Partner, Nivalion
  • Jean-Philippe Nerfin

    Group General Counsel, Pictet
  • Jean-René Oettli

    Partner, Barel & Borbey (Geneva)
  • Laetitia Pictet

    Chief Legal, Risk and Compliance Officer, DSM-Firmenich
  • Laure Lavorel

    Senior Associate General Counsel, Broadcom
  • Luisa Amate

    Lead Counsel, Corteva Agriscience
  • Nicolas Grégoire

    Head of Compliance, Richemont International SA
  • Oliver Drennan

    Group General Counsel, SITA
  • Prof. Sylvain Marchand

    Professor at the University of Geneva | Counsel, CMS
  • Sevan Antreasyan

    Partner, Lenz & Staehelin (Geneva)
  • Xavier Dedullen

    Managing Director, Kroll

Organized by

  • Logo GILA